
A transformative shift in addiction treatment and advocating for evidence-based approaches like naltrexone to offer personalized recovery paths beyond traditional abstinence models may be in the future for addiction treatment.
Dr Volpicelli is the executive director of the Institute of Addiction Medicine.
A transformative shift in addiction treatment and advocating for evidence-based approaches like naltrexone to offer personalized recovery paths beyond traditional abstinence models may be in the future for addiction treatment.
Struggling with alcohol use or concerned about early signs of addiction? Identifying unhealthy drinking patterns early can make a difference.
What are some of the best medical interventions for alcohol use disorder?
How can a whole-patient approach improve treatment for alcohol use disorder (AUD)? Joseph Volpicelli, MD, PhD, shares expert insights on evidence-based strategies, patient collaboration, and the role of medications like naltrexone in long-term recovery.
Joseph Volpicelli MD, PhD, reflects on 40 years of advancements in addiction treatment, from overcoming stigma to integrating evidence-based therapies like naltrexone.
How can personalized care, addressing comorbidities, and focusing on gradual improvement help increase treatment success for alcohol use disorder?
Tomorrow, August 31, is Overdose Awareness Day. What can you be doing to help prevent overdose deaths?
Published: January 23rd 2025 | Updated:
Published: January 24th 2025 | Updated:
Published: January 27th 2025 | Updated:
Published: January 20th 2025 | Updated:
Published: January 17th 2025 | Updated:
Published: January 15th 2025 | Updated: